Boehringer Ingelheim Pharma GmbH and Co. KG
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Germany
- Registered address
- Binger Strasse 173, Ingelheim am Rhein, Rhineland-Palatinate 55216, Germany (DEU)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 3002806556 · DUNS 551147440
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-05-15
- VAIDrug Quality Assurance2021-10-07
- VAIDrug Quality Assurance2018-05-04
- VAIDrug Quality Assurance2016-03-08
- VAIDrug Quality Assurance2014-03-07
- OAIDrug Quality Assurance2012-11-12
- NAIDrug Quality Assurance2010-02-05
- NAIDrug Quality Assurance2009-06-05
Drugs this plant is listed as making
14 distinct drugs across 32 products name this site in their FDA label.
- atropine sulfatein shortageAlcon Laboratories, Inc.
- dabigatran etexilateBoehringer Ingelheim Pharmaceuticals, Inc.
- dabigatran etexilate mesylateBoehringer Ingelheim Pharmaceuticals Inc.
- EmpagliflozinBoehringer Ingelheim Pharmaceuticals, Inc.
- empagliflozin and linagliptinBoehringer Ingelheim Pharmaceuticals, Inc.
- empagliflozin and metformin hydrochlorideBoehringer Ingelheim Pharmaceuticals, Inc.
- epinephrineAmneal Pharmaceuticals of New York LLC
- linagliptinBoehringer Ingelheim Pharmaceuticals, Inc.
- linagliptin and metformin hydrochlorideBoehringer Ingelheim Pharmaceuticals, Inc.
- olodaterol respimat inhalation sprayBoehringer Ingelheim Pharmaceuticals, Inc.
- telmisartan and hydrochlorothiazideBoehringer Ingelheim Pharmaceuticals, Inc.
- tiotropium bromide and olodaterolBoehringer Ingelheim Pharmaceuticals, Inc.
- tiotropium bromide inhalation sprayBoehringer Ingelheim Pharmaceuticals, Inc.
- tipranavirBoehringer Ingelheim Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.